Suppr超能文献

灌注大鼠肝脏摄取极低密度脂蛋白残粒的决定因素。

Determinants of the uptake of very low density lipoprotein remnants by the perfused rat liver.

作者信息

Arbeeny C M, Rifici V A, Handley D A, Eder H A

机构信息

Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461.

出版信息

Metabolism. 1987 Nov;36(11):1106-13. doi: 10.1016/0026-0495(87)90034-5.

Abstract

The receptor-mediated uptake of very low density lipoprotein (VLDL) remnants by the rat liver was studied. Livers were perfused with native 125I-VLDL remnants, radiolabeled apo E-deficient remnants, and radiolabeled remnants that contained reductively methylated apo B and unmodified apo E. The specific uptake of the apo E-deficient remnants was 20% of that for the native remnants, whereas the specific uptake of the remnants containing unreactive apo B was 78% of the control value. This suggests that the apo E of VLDL remnants is the principal ligand for binding to the receptor, and in the absence of apo E, apo B may participate in binding. This conclusion is supported by the finding that dimyristoyl phosphatidylcholine (DMPC)- apo E complexes were effective in competing for the hepatic uptake of 125I-VLDL remnants. The intracellular distribution of radioactivity was analyzed by Percoll density gradient centrifugation. At five minutes after perfusion, radioactivity was associated with the plasma membrane and lysosomal fractions, and at 30 minutes most of the radioactivity was associated with the lysosomal fraction. Binding and internalization of VLDL remnants was also directly visualized by electron microscopy. Internalization proceeded by coated pit-coated vesicle formation with subsequent delivery to lysosomes. Our findings demonstrate that the apo E of VLDL remnants mediates binding to the hepatic receptor and that the internalization and degradation of VLDL remnants is by a similar pathway to that previously described for LDL.

摘要

研究了大鼠肝脏对极低密度脂蛋白(VLDL)残余物的受体介导摄取。用天然125I-VLDL残余物、放射性标记的载脂蛋白E缺陷型残余物以及含有还原甲基化载脂蛋白B和未修饰载脂蛋白E的放射性标记残余物灌注肝脏。载脂蛋白E缺陷型残余物的特异性摄取量为天然残余物的20%,而含有无反应性载脂蛋白B的残余物的特异性摄取量为对照值的78%。这表明VLDL残余物的载脂蛋白E是与受体结合的主要配体,并且在没有载脂蛋白E的情况下,载脂蛋白B可能参与结合。二肉豆蔻酰磷脂酰胆碱(DMPC)-载脂蛋白E复合物能有效竞争肝脏对125I-VLDL残余物的摄取,这一发现支持了该结论。通过Percoll密度梯度离心分析放射性的细胞内分布。灌注后5分钟,放射性与质膜和溶酶体部分相关,30分钟时大部分放射性与溶酶体部分相关。通过电子显微镜也直接观察到了VLDL残余物的结合和内化。内化过程通过有被小窝-有被小泡形成,随后输送到溶酶体。我们的研究结果表明,VLDL残余物的载脂蛋白E介导与肝脏受体的结合,并且VLDL残余物的内化和降解途径与先前描述的低密度脂蛋白(LDL)相似。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验